TY - JOUR
T1 - Parenting a child with Marfan syndrome
T2 - Distress and everyday problems
AU - Warnink-Kavelaars, Jessica
AU - van Oers, Hedy A.
AU - Haverman, Lotte
AU - Buizer, Annemieke I.
AU - Alsem, Mattijs W.
AU - Engelbert, Raoul H.H.
AU - Menke, Leonie A.
N1 - Publisher Copyright:
© 2020 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.
PY - 2021/1
Y1 - 2021/1
N2 - Marfan syndrome (MFS) is a multisystemic, autosomal dominant connective tissue disorder that occurs de novo in 25%. In many families, parent and child(ren) are affected, which may increase distress in parents. To assess distress, 42 mothers (29% MFS) and 25 fathers (60% MFS) of 43 affected children, completed the validated screening-questionnaire Distress thermometer for parents of a chronically ill child, including questions on overall distress (score 0–10; ≥4 denoting “clinical distress”) and everyday problems (score 0–36). Data were compared to 1,134 control-group-parents of healthy children. Mothers reported significantly less overall distress (2, 1–4 vs. 3, 1–6; p =.049; r = −.07) and total everyday problems (3, 0–6 vs. 4, 1–8; p =.03; r = −.08) compared to control-group-mothers. Mothers without MFS reported significantly less overall distress compared to mothers with MFS, both of a child with MFS (1, 0–4 vs. 3.5, 2–5; p =.039; r = −.17). No significant differences were found between the father-groups, nor between the group of healthy parents of an affected child living together with an affected partner compared to control-group-parents. No differences in percentages of clinical distress were reported between mothers and control-group-mothers (33 vs. 42%); fathers and control-group-fathers (28 vs. 32%); nor between the other groups. Distress was not associated with the children's MFS characteristics. Concluding, parents of a child with MFS did not show more clinical distress compared to parents of healthy children. However, clinical distress was reported in approximately one-third and may increase in case of acute medical complications. We advise monitoring distress in parents of a child with MFS to provide targeted support.
AB - Marfan syndrome (MFS) is a multisystemic, autosomal dominant connective tissue disorder that occurs de novo in 25%. In many families, parent and child(ren) are affected, which may increase distress in parents. To assess distress, 42 mothers (29% MFS) and 25 fathers (60% MFS) of 43 affected children, completed the validated screening-questionnaire Distress thermometer for parents of a chronically ill child, including questions on overall distress (score 0–10; ≥4 denoting “clinical distress”) and everyday problems (score 0–36). Data were compared to 1,134 control-group-parents of healthy children. Mothers reported significantly less overall distress (2, 1–4 vs. 3, 1–6; p =.049; r = −.07) and total everyday problems (3, 0–6 vs. 4, 1–8; p =.03; r = −.08) compared to control-group-mothers. Mothers without MFS reported significantly less overall distress compared to mothers with MFS, both of a child with MFS (1, 0–4 vs. 3.5, 2–5; p =.039; r = −.17). No significant differences were found between the father-groups, nor between the group of healthy parents of an affected child living together with an affected partner compared to control-group-parents. No differences in percentages of clinical distress were reported between mothers and control-group-mothers (33 vs. 42%); fathers and control-group-fathers (28 vs. 32%); nor between the other groups. Distress was not associated with the children's MFS characteristics. Concluding, parents of a child with MFS did not show more clinical distress compared to parents of healthy children. However, clinical distress was reported in approximately one-third and may increase in case of acute medical complications. We advise monitoring distress in parents of a child with MFS to provide targeted support.
KW - autosomal dominant
KW - chronic illness
KW - connective tissue disorder
KW - distress
KW - Marfan syndrome
KW - parents
UR - http://www.scopus.com/inward/record.url?scp=85092190545&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.61906
DO - 10.1002/ajmg.a.61906
M3 - Article
C2 - 33034422
AN - SCOPUS:85092190545
SN - 1552-4825
VL - 185
SP - 50
EP - 59
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 1
ER -